Tom A. Gallo, MS, MDA
Virginia Cancer Institute
Thomas A. Gallo, MS, MDA, is executive director of the Virginia Cancer Institute in Richmond, Virginia, where he manages all aspects of a 24-provider medical oncology practice with 7 medical offices, ambulatory infusion centers, laboratories, and more than 200 employees.
Mr. Gallo is a member of the Board of Directors of MD Value Care, an ACO of independent physician practices; past president of the Executive Committee of the MGMA Administrators in Oncology-Hematology Assembly (AOHA); a current member and former president of the Board of Directors of the Virginia Association of Hematologists and Oncologists (VAHO); and a former board member of the Community Oncology Alliance. Mr. Gallo is an active and long-time member of the Association of Community Cancer Centers, Mr. Gallo was ACCC President-Elect (2017-2018) and was named 2018-2019 President of the Association of Community Cancer Centers (ACCC). He currently serves on the ACCC Governmental Affairs Committee and has previously served on the ACCC Board of Trustees (2004-2005).
He received a BA in Economics from the College of William and Mary in Williamsburg, Virginia, and an MS in Finance and a Master of Decision Analytics (MDA) degree from Virginia Commonwealth University, where he was a Dean’s Scholar.
Maya Leiva, PharmD, APP
Hematology/Oncology Advanced Practice Pharmacist
Maya Leiva, PharmD is an experienced Hematology and Oncology Advanced Practice Pharmacist and educator. She received her pharmacy degree with honors at Loma Linda University School of Pharmacy in 2010. Prior to pharmacy school, she completed her B.S. in Microbiology and was an NIH Fellow in the RISE program while pursuing her M.S. in Microbiology.
In addition to practicing in several states, she has had multiple faculty appointments at pharmacy schools across the U.S. She serves as a preceptor to pharmacy students and residents. She has subspecialties in supportive care, pain management, immuno-oncology, and clinical informatics.
She is involved in her community as a volunteer member of the Medical Reserve Corps for the Department of Health and Human Services and has additional training in disaster preparedness. She is affiliated with Inova Schar Cancer Institute in Falls Church, VA.
Greg Litton, MD
Gregory Litton MD, is a medical oncologist. Dr Litton earned his medical degree from the University of Washington School of Medicine in Seattle in 1983.
He served an internship and residency in Internal Medicine at the University of Wisconsin in Madison. Dr. Litton trained in research at the University of Wisconsin Clinical Cancer Center. He completed his clinical training with a fellowship in Hematology/Oncology at the University of Utah School of Medicine.
He is board certified in Internal Medicine and Medical Oncology. Dr. Litton has a specific clinical interest in the treatment of breast cancer and sarcomas.
Rex Mowat, MD
Hematologist and Medical Oncologist
Rex Mowat, MD is a board-certified hematologist and medical oncologist with the Toledo Clinic and is part of the cancer care team at the Maurer Family Cancer Care Center. Dr Mowat is an expert in Blood Cancers and benign conditions involving the blood and Lung cancer.
He received his medical degree from Wayne State University School of Medicine and his internship and residency at William Beaumont Hospital. He has been the Chief of Staff at Bixby Medical Center and was the medical director at Hickman Cancer Center. Dr Mowat been practicing medicine for over 30 years.
Edith A. Perez, MD
Hematologist and Medical Oncologist
Edith A. Perez, M.D., is a world-renowned American translational researcher and cancer specialist, known equally for her impact in designing innovative clinical trials and for her patient-centered humanitarian passion.
Dr. Perez earned her medical degree from the University of Puerto Rico School of Medicine in San Juan and completed her residency in internal medicine at the Loma Linda University Medical Center in California. In addition, she completed her fellowship training at the University of California, Davis. She received additional leadership training from the Wharton School of the University of Pennsylvania, in Philadelphia and the Harvard Executive Development Program at the Harvard Kennedy School, in Boston. Dr. Perez is board certiﬁed in internal medicine, medical oncology and hematology.
Dr. Perez joined Bolt Biotherapeutics in 2020 as its Chief Medical Oﬃcer. She also maintains her academic affiliation as Professor of Medicine with Mayo Clinic and holds leadership roles in various non-profit organizations, including The Donna Foundation and Stand Up to Cancer.
Joel Schaedler, CEO
Joel Schaedler is a seasoned healthcare executive with over twenty-four years of experience within the pharmaceutical, biotech, and specialty therapeutic arenas. His professional experience has been within the public and private sectors. He has worked in various executive leadership roles with three pharmaceutical and biotech organizations and was integral in the launch of seven FDA approved products. On the private side, he has been an active leader and principle of six, private specialty therapeutic organizations and has extensive experience with corporate entities within the cannabis arena. Outside of healthcare, Mr. Schaedler is a board member and active investor with four start-up enterprises within the commodities industry.
Mr. Schaedler is the founder and currently serves as Chief Executive Officer for Cornerstone Specialty Network, LLC. Cornerstone Specialty Network provides long-term, sustainable value through an aggregated network of Community Oncology practices. Founded in 2016, Cornerstone Specialty Network’s mission is to provide value to Community Oncology practices in order to help maximize the quality of patient care.